Scientists identify a neuronal enzyme linked to amyloid plaque formation, opening new possibilities for targeted Alzheimer’s disease treatment.

UniQure (NASDAQ:QURE) is one of the most promising low-cost stocks to buy now. On February 6, UniQure reported positive updated data from its Phase I/IIa trial of AMT-191, which is a gene therapy for ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa ...

A protein that has long frustrated diabetes researchers is suddenly at the center of a very different fight. By targeting an enzyme called protein tyrosine phosphatase 1B, or PTP1B, scientists are ...

Scientists reveal how Candida auris survives on human skin by feeding on CO₂ and how blocking it could stop its spread.

Xanthine oxidase inhibitors, primarily allopurinol and febuxostat, are the mainstay of treatment. The goal of chronic gout management includes lowering serum urate levels to below 6 mg/dL. 5 Overall, ...

September 17, 2008 (Munich, Germany) — A new study has found that early enzyme-replacement therapy brings the most benefit in patients with Fabry's disease. Dr Frank Weidemann (University Hospital ...

A clinical-stage biopharmaceutical company is testing a new targeted cancer treatment based on the notion that solid tumors can be compelled to develop their own chemotherapy and self-destruct. In PNP ...

NEW YORK (Reuters Health) - An enzyme has been recently identified that is able to degrade gluten in a laboratory simulation of the gastrointestinal tract. If clinical trials bear out the findings, ...